Earningsreport

Q1/2023 3/31/2023 EPS -0.090 ZacksConsensus -0.320 ActVsEst 0.230 - Beat

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors